ξεπθμεχΰρθ - ϊψιξδ 5 ξ"β

φεψϊ ξϊο

PER OS

ξιπεο

Chewable Tablets

ωιξεω αϊψετδ

Montelukast - Trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. Montelukast - Trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast - Trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast - Trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.

ξρτψ ψιωεν

146 93 33403 00

ιφψο

Trima Israel Pharmaceutical Products Maabarot Ltd, Israel

ϊεχσ ψιωιεο μϊψετδ

11/2011 - 10/2016

• ςμεο μφψλο

δερτϊ ϊβεαδ ηγωδ ων * λεϊψϊ * ςζεψ μπε μεεγΰ ωΰϊδ μΰ ψεαεθ δϊβεαδ ωμκ χιωεψιν ιδτλε αΰετο ΰεθεξθι μμηιφιν   αωμιηϊ ϊβεαδ ΰπι ξχαμ ΰϊ ϊπΰι δωιξεω αΰϊψ.